Many People With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Benefit From Ibrutinib Treatment Up To 8 Years: A Plain Language Summary.
Barr PM, Owen C, Robak T, Tedeschi A, Bairey O, Burger JA, Hillmen P, Dearden C, Grosicki S, McCarthy H, Li JY, Offner F, Moreno C, Jermain M, Zhou C, Hsu E, Szoke A, Kipps TJ, Ghia P.
Barr PM, et al. Among authors: bairey o.
Future Oncol. 2023 Jan 9. doi: 10.2217/fon-2022-0898. Online ahead of print.
Future Oncol. 2023.
PMID: 36617990
Free article.
Review.